Clinical Trial Update: The Use of PARO to Decrease Agitation in Persons With Dementia and/or Delirium [NA]

View source ↗

Summary

This update covers completion of a clinical trial evaluating the PARO robotic seal to decrease agitation in persons with dementia and/or delirium. The findings …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Dementia

Drugs mentioned

• PARO

Snippet

Sponsor: University of Pennsylvania | Conditions: Dementia, Delirium | NA | Status: COMPLETED